Inari Medical, Inc. (NARI) — Financial statements
Income statement, balance sheet, and cash flow for Inari Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 494↑28.7% | 383↑38.4% | 277↑98.3% | 140↑173.2% | 51 | |
| Cost of Revenue | 59↑32.7% | 45↑79.8% | 25↑88.9% | 13↑121.7% | 6 | |
| Gross Profit | 435↑28.2% | 339↑34.4% | 252↑99.3% | 127↑179.9% | 45 | |
| Operating Expenses | ||||||
| R&D Expenses | 88↑17.9% | 74↑45.5% | 51↑177.3% | 18↑154.8% | 7 | |
| General & Administrative Expenses | 349↑19.7% | 292↑53.6% | 190↑112.5% | 89↑140.4% | 37 | |
| Selling & Marketing Expenses | 1↑25.4% | 0.96↑178.2% | 0.34↑3.3% | 0.33 | 0.00 | |
| SG&A Expenses | 351↑19.7% | 293↑53.8% | 190↑112.1% | 90↑141.3% | 37 | |
| Other Expenses | 0.00↓100.0% | 0.36↑2077.8% | -0.02↑97.3% | -0.66↓222.7% | -0.21 | |
| Operating Expenses | 449↑22.2% | 367↑52.1% | 241↑123.2% | 108↑143.5% | 44 | |
| Total Costs & Expenses | 508↑23.3% | 412↑54.6% | 266↑119.5% | 121↑140.9% | 50 | |
| Operating Results | ||||||
| Operating Income | -14↑50.1% | -28↓521.1% | 7↓63.8% | 18↑2198.1% | 0.80 | |
| Depreciation & Amortization | 11↑40.6% | 8↑68.6% | 5↑205.1% | 1↑135.9% | 0.63 | |
| EBITDA | 15↑183.2% | -18↓217.7% | 16↓5.5% | 16↑4481.6% | 0.36 | |
| EBIT | 4↑117.2% | -26↓335.8% | 11↓26.4% | 15↑5599.5% | -0.27 | |
| Interest & Other Income | ||||||
| Net Interest Income | 15↑889.5% | 2↑1205.0% | -0.14↑78.3% | -0.65↑21.7% | -0.83 | |
| Interest Income | 16↑743.0% | 2↑1102.6% | 0.15↓68.2% | 0.48↑443.1% | 0.09 | |
| Interest Expense | 0.20↓33.3% | 0.29↓0.3% | 0.30↓74.0% | 1↑23.3% | 0.92 | |
| Non-Operating Income | -18↓736.7% | -2↓1523.5% | -0.14↓103.9% | 3↑225.9% | 1 | |
| Other Income / Expenses | 18↑855.0% | 2↑1303.8% | -0.16↑96.6% | -5↓132.3% | -2 | |
| Income Before Tax | 4↑116.2% | -26↓345.1% | 11↓22.5% | 14↑1257.0% | -1 | |
| Income Tax Expense | 6↑90.9% | 3↑264.7% | 0.85 | 0.00↓100.0% | 0.72 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -2↑94.4% | -29↓397.4% | 10↓28.6% | 14↑1256.8% | -1 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -2↑94.4% | -29↓397.4% | 10↓28.6% | 14↑823.0% | -2 | |
| Bottom-Line Net Income | -2↑94.4% | -29↓397.4% | 10↓28.6% | 14↑1256.8% | -1 | |
| EPS (Basic) | -0.03↑94.8% | -0.55↓375.0% | 0.20↓53.5% | 0.43↑1185.9% | -0.04 | |
| EPS (Diluted) | -0.03↑94.8% | -0.55↓405.6% | 0.18↓33.3% | 0.27↑781.8% | -0.04 | |
| Weighted Average Shares | 57↑7.4% | 53↑6.1% | 50↑55.5% | 32↓33.5% | 48 | |
| Weighted Average Diluted Shares | 57↑7.4% | 53↓5.0% | 56↑7.8% | 52↑7.0% | 48 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.